Ubicación: Global + English
Global Global Algérie Français Algeria English Angola Português Angola English Argentina Español Argentina English Australia English Austria Deutsch Austria English Azerbaijan English Azerbaijan Русский Bahrain English Bangladesh English Belgium English Belgium Français Belgium Nederlands Brazil Português Brazil English Bulgaria български Bulgaria English Cameroon English Cameroon Français Canada English Canada Français Chile Español Chile English China 中文 China 日本語 China English Colombia Español Colombia English Croatia English Czech Republic Čeština Czech Republic English Denmark English Djibouti English Ecuador Español Ecuador English Egypt English Estonia English Ethiopia English Finland Suomi Finland English France Français France English Georgia English Georgia Русский Germany Deutsch Germany English Ghana English Greece Ελληνικά Greece English Guatemala Español Guatemala English Hong Kong, China English Hong Kong, China 中文 Hungary Magyar Hungary English India English Indonesia English Iraq English Ireland English Italy Italiano Italy English Ivory Coast Français Ivory Coast English Japan 日本語 Japan English Jordan English Kazakhstan Русский Kazakhstan English Kenya English Kuwait English Kyrgyzstan Русский Kyrgyzstan English Latvia English Lithuania English Malaysia English Mauritius English Mauritius français (Maurice) Mexico Español Mexico English Moldova Română Moldova English Mongolia English Morocco English Morocco Français Mozambique Português Mozambique English Netherlands Nederlands Netherlands English New Zealand English Nigeria English Norway English Oman English Pakistan English Paraguay Español Paraguay English Peru Español Peru English Philippines English Poland Polski Poland English Portugal Português Portugal English Qatar English Republic of Korea 한국어 Republic of Korea English Romania Română Romania English Saudi Arabia English Serbia Српски Serbia English Singapore English Slovakia English Slovenia English South Africa English Spain English Spain Español Sri Lanka English Sweden English Switzerland Deutsch Switzerland Français Switzerland Italiano Switzerland English Tanzania English Thailand ไทย Thailand English Togo English Togo Français Tunisia English Tunisia Français Türkiye Türkçe Türkiye English Turkmenistan Русский Turkmenistan English Ukraine Українська Ukraine English United Arab Emirates English United Kingdom English Uruguay Español Uruguay English USA English Uzbekistan English Uzbekistan Русский Vietnam Tiếng Việt Vietnam English

TCA Cycle Intermediates Levels Detection: Quantitative Analysis of Central Carbon Metabolism

TCA cycle intermediates levels detection provides quantitative measurement of key metabolites in the tricarboxylic acid (citric acid) cycle, enabling precise evaluation of mitochondrial function and cellular energy metabolism. Using validated LC-MS/MS platforms with isotope-labeled internal standards, this analytical service supports research in cancer metabolism, metabolic disease, immunology, and mitochondrial disorders. Accurate profiling of citrate, α-ketoglutarate, succinate, fumarate, malate, and related intermediates delivers reliable data for mechanistic studies and biomarker discovery.

Technical Overview

The tricarboxylic acid (TCA) cycle, also known as the citric acid cycle or Krebs cycle, is the central hub of cellular metabolism, oxidizing acetyl-CoA to carbon dioxide while generating NADH and FADH2 that feed the electron transport chain. The cycle operates in the mitochondrial matrix and involves a series of organic acid intermediates that are continuously consumed and regenerated. Quantitative detection of these intermediates provides a direct readout of mitochondrial activity, flux through central carbon metabolism, and the balance between catabolic and anabolic pathways.

TCA cycle intermediates are chemically challenging analytes: they are small, highly polar organic acids, several of which (such as oxaloacetate and succinyl-CoA) are chemically unstable and prone to interconversion or degradation during sample handling. Consequently, reliable quantification requires rapid metabolic quenching, low-temperature extraction, and highly sensitive analytical instrumentation. Liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) operated in multiple reaction monitoring (MRM) mode has become the gold-standard approach, offering picomolar-to-nanomolar sensitivity, structural specificity, and the ability to quantify eight or more intermediates simultaneously from microgram-to-milligram quantities of biological material.

Alterations in TCA cycle intermediate levels are now recognized as informative biomarkers in a wide range of contexts, including oncogenic metabolic reprogramming, inherited mitochondrial enzyme deficiencies, inflammatory activation, hypoxia signaling, and drug-induced mitochondrial toxicity. Comprehensive intermediate profiling therefore serves as a powerful tool for both basic metabolic research and translational applications.

Testing Samples

Animal and Human Tissues

Fresh-frozen tissue specimens such as liver, heart, brain, skeletal muscle, kidney, adipose tissue, and tumor tissue are suitable for analysis. Tissues should be excised rapidly, rinsed briefly with cold saline to remove blood contamination, blotted dry, snap-frozen in liquid nitrogen, and stored at −80°C. A typical submission of 50–200 mg of tissue is sufficient, though optimized methods can accommodate smaller biopsy-scale samples.

Cultured Cells

Both adherent and suspension cell lines, as well as primary cells, can be analyzed. Proper metabolic quenching is critical: culture medium must be removed rapidly, cells washed with ice-cold saline to eliminate extracellular metabolites, and metabolism halted immediately using pre-chilled organic extraction solvent. Recommended input is approximately 1–5 × 10^6 cells per sample, with cell number or protein content recorded for normalization.

Blood-Derived Samples

Plasma and serum can be profiled for circulating TCA intermediates, which are relevant to systemic metabolic status and certain inborn errors of metabolism. Blood should be collected into EDTA or heparin tubes, processed within 30 minutes at 4°C to minimize ex vivo metabolic drift, and stored at −80°C. Hemolyzed samples are discouraged because erythrocyte metabolism substantially distorts intermediate concentrations.

Urine and Other Body Fluids

Urine is a well-established matrix for detecting TCA cycle disorders, particularly organic acidurias. Cerebrospinal fluid can also be analyzed for studies of central nervous system metabolism. Creatinine normalization is generally applied to urine results.

Isolated Mitochondria and Subcellular Fractions

Isolated mitochondria preparations permit direct assessment of cycle activity under defined substrate conditions. Because intermediates undergo rapid post-isolation change, mitochondria must be quenched and extracted immediately at the endpoint of incubation experiments.

Plant and Microbial Samples

Plant tissues (leaves, roots, seeds, fruits) and microbial cell pellets (bacteria, yeast, fungi) are compatible with the workflow, supporting research in plant stress physiology, post-harvest biology, and industrial fermentation monitoring.

Testing Items

The standard detection panel covers the principal intermediates of the tricarboxylic acid cycle:

  • Citric acid (citrate) — the six-carbon condensation product of oxaloacetate and acetyl-CoA; a key biosynthetic precursor for lipogenesis and an acetyl-CoA carrier between mitochondria and cytosol.
  • cis-Aconitic acid (cis-aconitate) — the transient intermediate of the aconitase reaction.
  • Isocitric acid (isocitrate) — substrate of isocitrate dehydrogenase (IDH), whose mutations produce the oncometabolite 2-hydroxyglutarate.
  • α-Ketoglutaric acid (α-ketoglutarate, 2-oxoglutarate) — a critical node linking the TCA cycle to amino acid transamination, nitrogen metabolism, and dioxygenase reactions governing epigenetics and HIF signaling.
  • Succinyl-CoA — the thioester intermediate of the α-ketoglutarate dehydrogenase complex; analysis requires specialized stabilization due to its inherent lability.
  • Succinic acid (succinate) — a metabolite with established signaling roles in inflammation, ischemia-reperfusion injury, and HIF-1α stabilization via succinate dehydrogenase inhibition.
  • Fumaric acid (fumarate) — elevated in fumarate hydratase-deficient tumors; acts as an endogenous inhibitor of α-ketoglutarate-dependent dioxygenases.
  • Malic acid (malate) — participates in the malate-aspartate shuttle and anaplerotic carbon transport.
  • Oxaloacetic acid (oxaloacetate) — chemically unstable and present at low abundance; quantified using rapid stabilization protocols or reported as the sum with aspartate-derived equivalents.

Optional add-on analytes frequently measured alongside the core panel include acetyl-CoA, pyruvate, lactate, the lactate/pyruvate ratio, 2-hydroxyglutarate, and the total NAD+/NADH redox pair, providing a more complete picture of central carbon and energy metabolism.

Testing Methods

Method selection depends on sample matrix, target analyte panel, and required sensitivity:

  • Liquid chromatography–tandem mass spectrometry (LC-MS/MS): The primary platform. Polar metabolites are separated on ion-exchange, HILIC, or reversed-phase columns with volatile buffer systems, then quantified by MRM transitions on a triple quadrupole mass spectrometer. Stable isotope-labeled internal standards (for example, uniformly 13C-labeled analogs) correct for matrix effects and extraction variability, enabling absolute quantification with calibration curves.
  • Ion chromatography–mass spectrometry (IC-MS): Provides superior chromatographic resolution for highly polar organic acids that are poorly retained on conventional columns.
  • GC-MS with derivatization: A complementary technique in which intermediates are converted to volatile derivatives (such as TBDMS or methyl esters) before analysis; historically important in organic acid screening and still valuable for confirmatory testing.
  • HPLC with UV or fluorescence detection: Suitable for high-abundance intermediates such as citrate in urine; lower sensitivity than MS-based methods but cost-effective for targeted applications.
  • Enzymatic spectrophotometric assays: Coupled NADH-dependent enzyme reactions permit measurement of individual intermediates (for example, citrate lyase-based citrate assays) in purified systems, though they lack multiplexing capability in complex matrices.

The general workflow comprises rapid sample quenching in pre-cooled (−20°C to −80°C) methanol/acetonitrile/water extraction solvent containing internal standards, homogenization, centrifugation to remove protein debris, optional concentration, LC-MS/MS analysis against matrix-matched calibration standards, and data processing with strict QC criteria including blanks, pooled QC injections, and replicate precision thresholds (typically CV < 15%). Results are reported in absolute concentrations such as nmol/g tissue, nmol/10^6 cells, or μmol/L fluid, together with method performance metrics such as linearity range, limit of detection, and recovery.

Applications

Quantitative TCA intermediate profiling supports research and diagnostics across multiple domains:

  • Cancer metabolism: Characterization of metabolic reprogramming in tumors, including IDH1/2 mutation-associated 2-hydroxyglutarate production, fumarate hydratase-deficient hereditary leiomyomatosis and renal cell cancer, succinate dehydrogenase (SDH)-deficient tumors, and assessment of therapeutic modulation of oxidative metabolism.
  • Mitochondrial medicine: Biochemical evaluation of suspected primary mitochondrial disease and enzyme deficiencies such as fumarase deficiency, α-ketoglutarate dehydrogenase deficiency, and combined respiratory chain disorders.
  • Inherited metabolic disorders: Urinary organic acid profiling for diagnosis and longitudinal monitoring of organic acidurias and allied inborn errors of metabolism.
  • Immunometabolism: Investigation of succinate accumulation and succinate receptor SUCNR1/GPR91 signaling in macrophage activation, inflammatory diseases, and immune cell differentiation.
  • Metabolic disease research: Studies of insulin resistance, type 2 diabetes, obesity, non-alcoholic fatty liver disease, and exercise physiology in which mitochondrial flux is centrally implicated.
  • Ischemia-reperfusion and cardiovascular studies: Monitoring succinate accumulation during ischemia and its oxidative consumption upon reperfusion as a driver of reactive oxygen species generation.
  • Neurodegeneration and brain metabolism: Mapping energy failure and anaplerotic compromise in Alzheimer's disease, Parkinson's disease, and stroke models.
  • Pharmacology and toxicology: Detection of drug-induced mitochondrial dysfunction and evaluation of metabolism-targeted therapeutics in preclinical development.
  • Plant science and industrial biotechnology: Analysis of stress responses, fruit quality, carbon partitioning, and fermentation process optimization.

FAQ

Why measure TCA cycle intermediates rather than just enzyme activity or oxygen consumption? Metabolite levels integrate enzyme activity, substrate availability, and pathway flux, capturing the functional output of the cycle. Intermediate accumulation or depletion often reveals regulatory bottlenecks that enzyme assays alone cannot show, and the data complement Seahorse-type respiration measurements.

Which intermediate is most susceptible to artifact, and how is this controlled? Oxaloacetate decarboxylates readily, and succinyl-CoA is hydrolytically labile. Artifacts are minimized by ultra-rapid quenching in cold organic solvent, avoidance of repeated freeze-thaw cycles, inclusion of isotope-labeled internal standards, and validated short autosampler residence times.

How much sample is required? Typical minimum inputs are 50 mg tissue, 1 × 10^6 cells, 100 μL plasma/serum, or 200 μL urine. Lower-input protocols can be arranged for precious specimens such as biopsies or sorted cell populations.

How should samples be shipped? Samples must be shipped frozen on dry ice with temperature monitoring, in clearly labeled, sealed tubes. Never ship samples on wet ice or at ambient temperature, as post-harvest metabolism will compromise results.

What are typical detection limits and turnaround time? LC-MS/MS methods generally achieve limits of quantification in the low nanomolar range with intra-day precision below 15% CV. Standard projects, including sample preparation, instrument analysis, and data reporting, are typically completed within 2–4 weeks depending on sample numbers and panel scope.

Can ratios and derived indices be calculated? Yes. Commonly reported derived parameters include the succinate/fumarate ratio, α-ketoglutarate/succinate ratio, lactate/pyruvate ratio, and citrate/α-ketoglutarate ratio, which provide insight into redox state, dioxygenase substrate availability, and mitochondrial dysfunction severity.

Why Choose ZKGX?

  • State-of-the-art analytical equipment
  • Highly qualified scientific team
  • Fast turnaround time
  • Competitive pricing